For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Tell me what you want, what you really, really want: How pharmacy could turn a crisis into a godsend
+News
In print
Feature
Tell me what you want, what you really, really want: How pharmacy could turn a crisis into a godsend
Tuesday 5 May 2020, 04:28 PM

Since the advent of the COVID-19 crisis, the New Zealand pharmacy sector has seen unprecedented and rapid changes. In the space of just a few weeks since the lockdown started, vaccination accreditation has been opened up, pharmacists have been permitted to vaccinate far more widely, and the legal requirements around prescriptions have been relaxed to name just a few. With so much change afoot, Pharmacy Today is asking what other updates pharmacists want to see
The COVID-19 pandemic has already created massive change throughout New Zealand society and community pharmacy has been at the forefront of much of it, Ian McMichael PSNZ president, Pharmaceutical Society president Ian McMichael
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.